Cemil Bilir

828 total citations
53 papers, 571 citations indexed

About

Cemil Bilir is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Cemil Bilir has authored 53 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Cemil Bilir's work include Thyroid Disorders and Treatments (4 papers), Nutrition and Health in Aging (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Cemil Bilir is often cited by papers focused on Thyroid Disorders and Treatments (4 papers), Nutrition and Health in Aging (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Cemil Bilir collaborates with scholars based in Türkiye, United States and Norway. Cemil Bilir's co-authors include Can Sarısözen, Hüseyin Engin, Gamze Güney Eskiler, Hakan Cinemre, Asuman Deveci Özkan, Süleyman Kaleli, Feyzi Gökosmanoğlu, Talat Bahçebaşı, Murat Can and Derya Demirtas and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Cemil Bilir

47 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cemil Bilir Türkiye 13 174 140 89 82 78 53 571
Milena Čavić Serbia 15 161 0.9× 189 1.4× 148 1.7× 84 1.0× 59 0.8× 59 682
Xiuzhen Li China 13 227 1.3× 90 0.6× 71 0.8× 56 0.7× 48 0.6× 33 528
Tsuyoshi Nagata Japan 9 213 1.2× 82 0.6× 74 0.8× 66 0.8× 103 1.3× 15 530
Dilinaer Bolati Japan 9 284 1.6× 56 0.4× 62 0.7× 134 1.6× 62 0.8× 10 760
Hai‐Yan Qian China 11 243 1.4× 60 0.4× 70 0.8× 77 0.9× 48 0.6× 21 547
Randa H. Mohamed Egypt 17 216 1.2× 88 0.6× 49 0.6× 75 0.9× 82 1.1× 42 732
Arpita Vyas United States 11 222 1.3× 174 1.2× 55 0.6× 27 0.3× 72 0.9× 22 616
Ning Zhu China 19 340 2.0× 187 1.3× 171 1.9× 72 0.9× 92 1.2× 61 817

Countries citing papers authored by Cemil Bilir

Since Specialization
Citations

This map shows the geographic impact of Cemil Bilir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cemil Bilir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cemil Bilir more than expected).

Fields of papers citing papers by Cemil Bilir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cemil Bilir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cemil Bilir. The network helps show where Cemil Bilir may publish in the future.

Co-authorship network of co-authors of Cemil Bilir

This figure shows the co-authorship network connecting the top 25 collaborators of Cemil Bilir. A scholar is included among the top collaborators of Cemil Bilir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cemil Bilir. Cemil Bilir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uras, Cihan, Mahmut Çerkez Ergören, Cemil Bilir, et al.. (2025). P044: Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey. The Breast. 80. 103928–103928.
2.
Eskiler, Ersin, et al.. (2023). Determinants of Cancer-Related Online Information-Seeking Intentions of Cancer Patients Receiving Chemotherapy. Online Türk Sağlık Bilimleri Dergisi. 8(4). 490–496.
3.
Bilir, Cemil, et al.. (2021). Has the COVID-19 Pandemic Increased Mortality Among Patients with Cancer Receiving Systemic Anticancer Treatments?. Journal of College of Physicians And Surgeons Pakistan. 31(1). S66–S70. 2 indexed citations
4.
Eskiler, Gamze Güney & Cemil Bilir. (2021). The efficacy of indoximod upon stimulation with pro-inflammatory cytokines in triple-negative breast cancer cells. Immunopharmacology and Immunotoxicology. 43(5). 554–561. 7 indexed citations
5.
Bilir, Cemil, İlhan Hacıbekiroğlu, İbrahim Vedat Bayoğlu, et al.. (2021). Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer. Scientific Reports. 11(1). 14131–14131. 6 indexed citations
6.
Eskiler, Gamze Güney, et al.. (2021). Mechanisms of abemaciclib, a CDK4/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro. Translational Oncology. 15(1). 101243–101243. 10 indexed citations
7.
Eskiler, Gamze Güney, et al.. (2019). IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia. Bratislavské lekárske listy/Bratislava medical journal. 120(11). 819–826. 39 indexed citations
8.
Pujol, Jean-Louis, Amandine Coffy, Andrea Camerini, et al.. (2019). An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer. PLoS ONE. 14(8). e0220988–e0220988. 19 indexed citations
9.
Bedir, Recep, et al.. (2016). Relationship Between The 18F-FDG Uptake with Ki-67 and P53 Expression in Patients with Lung Cancer: A Clino-Pathologic Study. DergiPark (Istanbul University). 2(3). 1 indexed citations
10.
Bilir, Cemil, et al.. (2016). Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancersfor The Treatment of Cancer Related Pain. DergiPark (Istanbul University). 2(2). 1 indexed citations
11.
Yaylacı, Selçuk, et al.. (2015). Is there a difference in mad honey poisoning between geriatric and non-geriatric patient groups?. PubMed. 19(23). 4647–53. 6 indexed citations
12.
13.
Bilir, Cemil, et al.. (2013). Increased Mean Platelet Volume in Deep Vein Thrombosis Patients With Cancer. 2(2). 64–68. 1 indexed citations
14.
Cevrioğlu, Arif Serhan, et al.. (2013). Platelet Indices and Blood Groups in Early Recurrent Miscarriage: A Study in Pregnant Women. Journal of Clinical Gynecology and Obstetrics. 2(1). 27–30. 1 indexed citations
15.
Engin, Hüseyin & Cemil Bilir. (2013). Chemotherapy in Elderly Patients with Metastatic Gastric Cancer; a Single Turkish Cancer Center Experience. Annals of Oncology. 24. iv60–iv60. 1 indexed citations
16.
Engin, Hüseyin, Cemil Bilir, & İshak Özel Tekin. (2013). Prognostic Significance of Peripheral Blood Flow Cytometry Parameters in Patients with Non-Metastatic Breast Cancer. Asian Pacific Journal of Cancer Prevention. 14(12). 7645–7649. 8 indexed citations
17.
Özden, Selçuk, et al.. (2013). Increased serum procalcitonin levels in pregnant patients with asymptomatic bacteriuria. Annals of Clinical Microbiology and Antimicrobials. 12(1). 25–25. 13 indexed citations
18.
Bilir, Cemil, et al.. (2012). Acute Myocardial Infarction Caused by Filgrastim: A Case Report. SHILAP Revista de lepidopterología. 2012. 1–2. 2 indexed citations
20.
Cinemre, Hakan, Cemil Bilir, Feyzi Gökosmanoğlu, & Talat Bahçebaşı. (2008). Hematologic Effects of Levothyroxine in Iron-Deficient Subclinical Hypothyroid Patients: A Randomized, Double-Blind, Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 94(1). 151–156. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026